| BBB | Blood–brain barrier |
| CCHFV | Crimean–Congo hemorrhagic fever virus |
| CCL2 | Monocyte chemoattractant protein-1; MCP-1 |
| CCL4/MIP-1β | C-C motif chemokine ligand 4/Macrophage inflammatory protein 1β |
| CCL5/RANTES | C-C motif chemokine ligand 5/Regulated upon activation, normal T cell expressed and presumably secreted |
| CDI | Chronic diffuse infection |
| CFI | Chronic focal infection |
| CNS | Central nervous system |
| CXCL10/IP10 | Gamma-interferon-inducible protein-10; IP-10 |
| EBV | Epstein–Barr Virus |
| EV71 | Enterovirus 71 |
| GAS | Gamma interferon activation site |
| GDI | Guanine nucleotide-dissociated inhibitor |
| GFAP | Glial fibrillary acidic protein |
| HCoV-OC43 | Human coronavirus OC43 |
| HIV-1 | Human immunodeficiency virus 1 |
| HSV-1 | Herpes simplex virus-1 |
| IFN | Interferon |
| IFNAR | IFNα/β receptor |
| IL | Interleukin |
| IRF | IFN-regulatory factor |
| ISG | Interferon-stimulated gene |
| JEV | Japanese encephalitis virus |
| MERS-CoV | Middle East respiratory syndrome virus |
| MHC | Major histocompatibility complex |
| MVB | Multivesicular body |
| NLR | NOD-like receptor |
| PRR | Pattern-recognition receptor |
| RABV | Rabies virus |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| TBEV | Tick-borne encephalitis virus |
| TGF-β1 | Transforming growth factor β1 |
| TI | Tiht junction |
| TMEV | Theiler’s murine encephalomyelitis virus |
| VSV | Vesicular stomatitis virus |
| WEEV | Western equine encephalitis virus |
| WNV | West Nile virus |
| ZIKV | Zika virus |